Who we are
EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production, and commercialization of products in the areas of neurology and specialty injectables, covering oncology, intensive care and hormone therapeutics.
From our headquarters in Austria, we run a dynamic operation providing innovative products and value-added formulations aimed at enhancing the lives of patients and supporting the work of healthcare professionals through improved convenience and safety.
Our products are developed and manufactured at our EU GMP certified facilities in Austria and Germany. These are highly specialized in the production of complex injectables including high potency and controlled substances, crystal suspensions, as well as oily solutions in vials, pre-filled syringes, cartridges, implants, and ampoules.
We market our products in more than 80 countries around the world through our own international affiliates and strategic partners.
EVER Pharma
HQ & Production – Unterach, Austria
EVER Pharma’s corporate headquarter is located in Unterach near Salzburg. Our associates work on the development and production of innovative therapies and high-quality pharmaceutical formulations for worldwide distribution. The production site in Austria is dedicated to the manufacture of active pharmaceutical ingredients.
EVER Pharma Jena
Production – Jena, Germany
EVER Pharma combines experience from over 60 years of sterile production with innovative know-how and high-quality manufacturing technology. High-quality complex injectables including high potency and controlled substances, crystal suspensions, as well as oily solutions in vials, pre-filled syringes, cartridges, implants, and ampoules are produced for the supply of EVER Pharma’s products around the world as well as third party customers.
Founded as Jenapharm in 1950, the site has undergone extensive investments, including technological modernization and the construction of a new production facility. In 2001, the site was acquired by Hexal which became part of Novartis until 2011 when EVER Pharma acquired the site and established EVER Pharma Jena GmbH. As part of the business expansion, EVER Pharma invested over €200 million in state-of-the-art manufacturing facilities that have been commissioned in 2021.
Company Video
Competence through expertise
Through dedicated research, focus on highly specialized therapeutic areas and an international outlook, we have established a solid platform that enables us to make a considerable contribution to healthcare systems around the world.
Facts & Figures
Foundation
The EVER Group was founded in Austria in 1934.
Headquarters & Production sites
EVER Pharma is headquartered in Unterach, Austria with production and research facilities in Austria, Germany, and the US.
Product range
EVER Pharma markets high-quality products in over 70 countries worldwide through its own representative offices and sales partners.
Number of employees
Over 1,000 employees worldwide.
Research & Development
EVER Pharma invests around €25 million annually in R&D.
Indication areas
EVER Pharma specializes in the areas of neurology and specialty injectables, including oncology, intensive care and hormone therapeutics.
Authority audits / certifications
ISO 13485, ISO 16247, ISO 14001, EU-GMP, GCC (MENA), CFDA (China), ANVISA (Brazil), RU-GMP, PDMA (Japan)